What is so special about apolipoprotein AI in reverse cholesterol transport?
An initial step in reverse cholesterol transport is the movement of unesterified cholesterol from peripheral cells to high-density lipoproteins (HDLs). This transfer usually occurs in extracellular spaces, such as the subendothelial space of a vessel wall, and is promoted by the interaction of lipid-free or lipid-poor apolipoprotein (apo)AI with ATP binding cassette A1 cellular transporters on macrophages (MPhi). Because HDL does not interact with MPhi ATP binding cassette A1 and apoAI is not synthesized by macrophages, this apoAI must be generated from spherical HDL. In this brief review, we propose that spherical apoAI is derived from HDL by remodeling events that are accomplished by proteins secreted by cholesteryl ester-loaded foam cells, including the lipid transfer proteins, phospholipid transfer protein, and cholesteryl ester transfer protein, and the triglyceride hydrolases hepatic lipase and lipoprotein lipase.
Curtiss
Linda K
LK
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA. lcurtiss@scripps.edu
Valenta
David T
DT
Hime
Neil J
NJ
Rye
Kerry-Anne
KA
D000818:Animals; D016632:Apolipoprotein A-I / Q000235:genetics / Q000378:metabolism*; D001692:Biological Transport / Q000502:physiology; D008076:Cholesterol, HDL / Q000378:metabolism*; D005487:Foam Cells / Q000378:metabolism*; D006801:Humans
D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL